New Study Shows Azithromycin May Put Asthma Into Remission

Researchers at HMRI and the University of Newcastle have found that remission can be achieved in up to 50% of moderate to severe asthma patients treated with long-term azithromycin, a low-cost oral therapy. This groundbreaking study, published in the journal Chest 2024, offers a new approach to asthma treatment with significant health and economic implications.